Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

    Autologous hematopoietic stem cell transplantation (aHSCT) is a promising therapy for multiple sclerosis (MS), which has mainly been used in adults. The purpose of this study was to investigate efficacy and ad...

    J Burman, K Kirgizov, K Carlson, M Badoglio, G L Mancardi in Bone Marrow Transplantation (2017)

  2. No Access

    Article

    Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation

    Marie C. Katz, Sebastian Michaelis, Darina M. Siegmund in Bone Marrow Transplantation (2018)

  3. No Access

    Article

    Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome

    Some patients with systemic lupus erythematosus (SLE) are refractory to traditional therapies, dependent on chronic corticosteroids, have organ damage, and are at high risk of mortality. In this group of patie...

    Richard K. Burt, **aoqiang Han, Paula Gozdziak, Kim Yaung in Bone Marrow Transplantation (2018)

  4. No Access

    Article

    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

    P. Tappenden, Y. Wang, B. Sharrack, J. Burman, M. Kazmi in Bone Marrow Transplantation (2020)

  5. Article

    Open Access

    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease

    Patients with advanced Ewing sarcoma (AES) carry a poor prognosis. Retrospectively, we analyzed 66 AES patients treated with allogeneic stem cell transplantation (allo-SCT) receiving HLA-mismatched (group A, n = ...

    U. Thiel, S. J. Schober, A. Ranft, H. Gassmann, S. Jabar in Bone Marrow Transplantation (2021)

  6. No Access

    Article

    Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease

    Limited information is available regarding clinical and biological properties of fatigue in patients with chronic graft-versus-host disease (cGvHD). Patients with moderate-to-severe cGvHD per NIH criteria were...

    Sencer Goklemez, Leorey N. Saligan, Filip Pirsl in Bone Marrow Transplantation (2021)

  7. No Access

    Article

    Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes

    Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca in Bone Marrow Transplantation (2022)

  8. No Access

    Article

    Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis

    Cardiovascular diseases are an emerging cause of mortality and morbidity in survivors of hematopoietic stem cell transplantation (HSCT); however, the incidence of cardiovascular events (CVEs) in this populatio...

    N. Aghel, M. Lui, V. Wang, D. Khalaf, H. Mian, C. Hillis in Bone Marrow Transplantation (2023)

  9. Article

    Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

    Raffaella Greco, Jorinde D. Hoogenboom in Bone Marrow Transplantation (2023)

  10. No Access

    Article

    No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma

    Tristan E. Knight, Kwang Woo Ahn, Kyle M. Hebert in Bone Marrow Transplantation (2023)

  11. Article

    Open Access

    Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation

    The intensity of the conditioning regimen given before allogeneic hematopoietic cell transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently developed transplant conditioning ...

    Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl in Bone Marrow Transplantation (2024)

  12. No Access

    Article

    Human-in-the-loop avatar chatbot shows promise in supporting hematopoietic stem cell transplantation patients

    Amar H. Kelkar, Chantal Kerssens, Nicholas Groblewski in Bone Marrow Transplantation (2024)

Page of 2 next disabled